Short answer
Ardent Health, Inc. (ARDT) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Information generally excluded from Section 18 liability and Securities Act or Exchange Act incorporation by reference.
Ardent Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Information generally excluded from Section 18 liability and Securities Act or Exchange Act incorporation by reference
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $1.602B, up 7.0% YoY, driven by adjusted admissions growth and 5.5% higher revenue per adjusted admission
- Adjusted EBITDA $124M, up 26.3%; excluding a $10.9M investment-option gain, underlying growth was 15%
- Net income attributable to Ardent $40M, down from $41M; diluted EPS $0.28 versus $0.29
- Full-year guidance reaffirmed: revenue $6.4B–$6.7B and adjusted EBITDA $485M–$535M
- Liquidity remained substantial at $0.9B, with $1.1B debt and lease-adjusted net leverage improving to 2.6x from 3.0x
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Ardent Health, Inc. 8-K filings
Get the next ARDT 8-K as it lands
Follow ARDT for push alerts, or ask the research agent what this filing means.